BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 905 filers reported holding BAXTER INTL INC in Q4 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $4,414,898 | +12.4% | 131,985 | +43.6% | 0.01% | 0.0% |
Q1 2024 | $3,928,020 | -59.1% | 91,905 | -63.0% | 0.01% | -51.7% |
Q4 2023 | $9,615,206 | +296.7% | 248,712 | +287.3% | 0.03% | +141.7% |
Q3 2023 | $2,423,738 | +2.6% | 64,222 | +23.9% | 0.01% | 0.0% |
Q2 2023 | $2,361,739 | +17.5% | 51,838 | +4.6% | 0.01% | +20.0% |
Q1 2023 | $2,009,829 | -5.7% | 49,552 | +18.5% | 0.01% | -33.3% |
Q4 2022 | $2,131,362 | -76.5% | 41,816 | -75.1% | 0.02% | -72.2% |
Q3 2022 | $9,052,000 | +17.5% | 168,063 | +40.1% | 0.05% | +45.9% |
Q2 2022 | $7,707,000 | -37.9% | 119,977 | -25.1% | 0.04% | +8.8% |
Q1 2022 | $12,419,000 | -59.0% | 160,165 | -54.7% | 0.03% | -33.3% |
Q4 2021 | $30,319,000 | -16.9% | 353,200 | -22.1% | 0.05% | -30.1% |
Q3 2021 | $36,487,000 | +34.1% | 453,655 | +34.2% | 0.07% | +17.7% |
Q2 2021 | $27,209,000 | +9.7% | 337,989 | +15.0% | 0.06% | -15.1% |
Q1 2021 | $24,796,000 | +2.7% | 294,000 | -2.3% | 0.07% | -9.9% |
Q4 2020 | $24,142,000 | -15.9% | 300,872 | -15.8% | 0.08% | -44.9% |
Q3 2020 | $28,721,000 | +9.4% | 357,139 | +17.1% | 0.15% | -15.0% |
Q2 2020 | $26,260,000 | -0.5% | 305,000 | -6.2% | 0.17% | -59.3% |
Q1 2020 | $26,403,000 | -10.8% | 325,200 | -8.1% | 0.42% | +165.6% |
Q4 2019 | $29,601,000 | +36.2% | 354,000 | +42.5% | 0.16% | +7.4% |
Q3 2019 | $21,728,000 | +44.5% | 248,400 | +35.3% | 0.15% | +36.7% |
Q2 2019 | $15,039,000 | +33.6% | 183,626 | +32.6% | 0.11% | +4.8% |
Q1 2019 | $11,257,000 | +134.8% | 138,446 | +90.0% | 0.10% | +76.3% |
Q4 2018 | $4,795,000 | +56.6% | 72,848 | +83.4% | 0.06% | +73.5% |
Q3 2018 | $3,062,000 | -38.7% | 39,714 | -64.7% | 0.03% | -77.9% |
Q4 2016 | $4,993,000 | +169.7% | 112,619 | +189.5% | 0.15% | +275.6% |
Q3 2016 | $1,851,000 | -61.4% | 38,905 | -63.3% | 0.04% | -55.4% |
Q2 2016 | $4,796,000 | +429.9% | 106,063 | +284.7% | 0.09% | +338.1% |
Q3 2015 | $905,000 | -91.2% | 27,570 | -80.7% | 0.02% | -81.9% |
Q3 2014 | $10,248,000 | +856.9% | 142,800 | +827.3% | 0.12% | +866.7% |
Q4 2013 | $1,071,000 | -91.5% | 15,400 | -92.0% | 0.01% | -90.6% |
Q3 2013 | $12,664,000 | – | 192,800 | – | 0.13% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |